Alogliptin Benzoate

苯甲酸阿格列汀

Report date: 2022/05/17 17:51:40
NME

Base Information

Drug NameAlogliptin Benzoate
Drug Alias Namealogliptina阿罗格列汀阿格列汀苯甲酸盐alogliptinealogliptinum +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDipeptidyl peptidase IV inhibitors
TargetsDipeptidyl peptidase IV
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes MellitusAcute Coronary Syndrome
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaDiabetes Mellitus, Type 2
Original Approved Country/TerritoryJapan
Original Approved Date2010/04/06
Country/TerritoryCzechiaBelgiumBulgaria +[56] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHuadong Medicine Co LtdTakeda Pharmaceuticals USA IncTeijin Pharma Ltd +[6] 
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsDiabetes MellitusAcute Coronary Syndrome

Other Information

ATC CodeA10BH04
Related LinksWikipediaDrugBankKEGG